High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosis

Abstract

We confirm a significant association between high PPI exposure with severity of calcinosis in SSc. Given the clinical impact of calcinosis and reflux in SSc, PPI exposure as a potentially modifiable risk factor for calcinosis requires further evaluation.